AU4134996A - Method of inhibiting nitric oxide formation - Google Patents

Method of inhibiting nitric oxide formation

Info

Publication number
AU4134996A
AU4134996A AU41349/96A AU4134996A AU4134996A AU 4134996 A AU4134996 A AU 4134996A AU 41349/96 A AU41349/96 A AU 41349/96A AU 4134996 A AU4134996 A AU 4134996A AU 4134996 A AU4134996 A AU 4134996A
Authority
AU
Australia
Prior art keywords
nitric oxide
oxide formation
inhibiting nitric
inhibiting
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41349/96A
Inventor
John A Corbett
Michael L Mcdaniel
Ronald G Tilton
Joseph R Williamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU4134996A publication Critical patent/AU4134996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU41349/96A 1994-10-25 1995-10-25 Method of inhibiting nitric oxide formation Abandoned AU4134996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32892594A 1994-10-25 1994-10-25
PCT/US1995/013788 WO1996012483A1 (en) 1994-10-25 1995-10-25 Method of inhibiting nitric oxide formation
US328925 1999-06-09

Publications (1)

Publication Number Publication Date
AU4134996A true AU4134996A (en) 1996-05-15

Family

ID=23283069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41349/96A Abandoned AU4134996A (en) 1994-10-25 1995-10-25 Method of inhibiting nitric oxide formation

Country Status (2)

Country Link
AU (1) AU4134996A (en)
WO (1) WO1996012483A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018392A1 (en) * 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
US6855511B2 (en) 1998-09-25 2005-02-15 Protemix Corporation Limited Fructosamine oxidase assay: methods and materials

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045108A1 (en) * 1996-05-30 1997-12-04 Children's Hospital Medical Center Guanidino derivatives as inhibitors of the cytotoxic effect of peroxynitrite
US5780513A (en) * 1996-08-22 1998-07-14 Washington University Method of inhibiting the release of bioactive IL-1
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
JP2001511151A (en) * 1997-02-04 2001-08-07 ザ ジェネラル ホスピタル コーポレイション How to treat epidermis or skin disease and transformed animals
US6093745A (en) * 1997-11-25 2000-07-25 Psorx, L.L.C. Methods and composition for treating skin proliferative diseases
ES2386782T3 (en) 2002-03-08 2012-08-30 Philera New Zealand Limited Prevention and / or treatment of cardiovascular disease and / or associated heart failure
US20060100278A1 (en) 2002-08-20 2006-05-11 Cooper Garth J S Dosage forms and related therapies
EP1778618B1 (en) 2004-07-19 2013-12-25 PhilERA New Zealand Limited Synthesis of triethylenetetramines
CN114681438B (en) * 2022-05-17 2024-03-19 中国医学科学院基础医学研究所 Use of metformin and other guanidine-containing compounds for reversing the crystallization tendency of Gal-10 and for alleviating the associated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US5317040A (en) * 1993-01-26 1994-05-31 Washington University Method for the treatment of pertussis with aminoguanidine

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610693B2 (en) 1998-09-19 2003-08-26 Protemix Corporation Limited Fructosamine oxidase: antagonists and inhibitors
WO2000018392A1 (en) * 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
US6348465B1 (en) 1998-09-25 2002-02-19 Protemix Corporation Limited Fructosamine oxidase: antagonists and inhibitors
US6855511B2 (en) 1998-09-25 2005-02-15 Protemix Corporation Limited Fructosamine oxidase assay: methods and materials
US6897243B2 (en) 1998-09-25 2005-05-24 Protemix Corporation Limited Fructosamine oxidase: antagonists and inhibitors
US7928094B2 (en) 1998-09-25 2011-04-19 Philera New Zealand Limited Treatment of diabetes with copper binding compounds

Also Published As

Publication number Publication date
WO1996012483A1 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
KR0130138B1 (en) Method of exhavsing silicon oxide
EP0704885A3 (en) Method of depositing fluorine doped oxide
AU2339295A (en) Process for the purification of nitric oxide
AU2018995A (en) Process for the purification of nitric oxide
AU4149696A (en) Substituted heterocycles as inhibitors of nitric oxide synthase
AU4013193A (en) Method of maintaining relationships between elements
AU2773195A (en) Improved wafer and method of making same
EP0966525A4 (en) Method of using tetracycline compounds for inhibition of nitric oxide production
AU643420B3 (en) Improved wheel and method of forming same
AU4985993A (en) Toothbrush and method for making such toothbrush
AU4515696A (en) Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
AU4515896A (en) Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
AU6947494A (en) Filter and method of forming
ZA969765B (en) Lithium manganese oxide compound and method of preparation.
AU6400294A (en) Tripterinin compound and method
ZA969766B (en) Lithium manganese oxide compound and method of preparation.
AU1169092A (en) Method of brazing
AU4134996A (en) Method of inhibiting nitric oxide formation
EP0767258A3 (en) Method of manufacturing oxide crystal
AU2970595A (en) Inhibition of virus by nitric oxide
AU2919995A (en) A compound toothpast and the method of making it
AU3399997A (en) Process for the reduction of copper oxide
GB9226309D0 (en) Improved method of manufacture
AU1346995A (en) Method of insulating structures
AU2966695A (en) Method and compound for the treatment of hair loss